GLOBAL BIO-CHEM (00809) announced its interim results, reporting a net loss of approximately HKD 207 million, an increase of 33.69% year-on-year.

20:14 28/08/2026

Dacheng Biochemical Technology (00809) announced its interim results for 2026, with revenue of approximately HKD 1.004 billion, a year-on-year decrease of 15.36%; a net loss of approximately HKD 207 million, a year-on-year increase of 33.69%; and a loss per share of HKD 0.12.

GLOBAL BIO-CHEM (00809) announced its interim results for 2026, with revenue of approximately HK$1.004 billion, a year-on-year decrease of 15.36%; a net loss of approximately HK$207 million, a year-on-year increase of 33.69%; and a loss per share of HK$0.12.

READBOY (02385) released its interim results, reporting a loss attributable to shareholders of 31.285 million yuan, a year-on-year decrease of 29.63%.

ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.

CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.

READBOY (02385) released its interim results, reporting a loss attributable to shareholders of 31.285 million yuan, a year-on-year decrease of 29.63%.

ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.

CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.